176 related articles for article (PubMed ID: 22848296)
1. A possible predictive marker of progression for hepatocellular carcinoma.
DI Stasio M; Volpe MG; Colonna G; Nazzaro M; Polimeno M; Scala S; Castello G; Costantini S
Oncol Lett; 2011 Nov; 2(6):1247-1251. PubMed ID: 22848296
[TBL] [Abstract][Full Text] [Related]
2. Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer.
Zhu Y; Pu Q; Zhang Q; Liu Y; Ma Y; Yuan Y; Liu L; Zhu W
Cancer Med; 2023 Aug; 12(16):17149-17170. PubMed ID: 37606338
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer.
Zhu C; Wang S; Du Y; Dai Y; Huai Q; Li X; Du Y; Dai H; Yuan W; Yin S; Wang H
BMC Gastroenterol; 2022 Oct; 22(1):437. PubMed ID: 36253721
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B Virus-X Downregulates Expression of Selenium Binding Protein 1.
Lee YM; Kim S; Park RY; Kim YS
Viruses; 2020 May; 12(5):. PubMed ID: 32443734
[TBL] [Abstract][Full Text] [Related]
5. Reduced selenium-binding protein 1 in breast cancer correlates with poor survival and resistance to the anti-proliferative effects of selenium.
Zhang S; Li F; Younes M; Liu H; Chen C; Yao Q
PLoS One; 2013; 8(5):e63702. PubMed ID: 23704933
[TBL] [Abstract][Full Text] [Related]
6. Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Chen F; Chen C; Qu Y; Xiang H; Ai Q; Yang F; Tan X; Zhou Y; Jiang G; Zhang Z
Medicine (Baltimore); 2016 Aug; 95(35):e4592. PubMed ID: 27583873
[TBL] [Abstract][Full Text] [Related]
7. Serum Selenium-Binding Protein 1 (SELENBP1) in Burn Injury: A Potential Biomarker of Disease Severity and Clinical Course.
Turan TL; Klein HJ; Hackler J; Hoerner L; Rijntjes E; Graf TR; Plock JA; Schomburg L
Antioxidants (Basel); 2023 Oct; 12(11):. PubMed ID: 38001780
[TBL] [Abstract][Full Text] [Related]
8. Diminished CCl
Elkhamesy A; Refaat M; Gouida MSO; Alrdahe SS; Youssef MM
J Food Biochem; 2022 Apr; 46(4):e13845. PubMed ID: 34231234
[TBL] [Abstract][Full Text] [Related]
9. Selenium-Binding Protein 1 Indicates Myocardial Stress and Risk for Adverse Outcome in Cardiac Surgery.
Kühn-Heid ECD; Kühn EC; Ney J; Wendt S; Seelig J; Schwiebert C; Minich WB; Stoppe C; Schomburg L
Nutrients; 2019 Aug; 11(9):. PubMed ID: 31450690
[TBL] [Abstract][Full Text] [Related]
10. The role of copper, molybdenum, selenium, and zinc in nutrition and health.
Chan S; Gerson B; Subramaniam S
Clin Lab Med; 1998 Dec; 18(4):673-85. PubMed ID: 9891606
[TBL] [Abstract][Full Text] [Related]
11. Current Trends on the Involvement of Zinc, Copper, and Selenium in the Process of Hepatocarcinogenesis.
Himoto T; Masaki T
Nutrients; 2024 Feb; 16(4):. PubMed ID: 38398797
[TBL] [Abstract][Full Text] [Related]
12. Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity.
Silvers AL; Lin L; Bass AJ; Chen G; Wang Z; Thomas DG; Lin J; Giordano TJ; Orringer MB; Beer DG; Chang AC
Clin Cancer Res; 2010 Apr; 16(7):2009-21. PubMed ID: 20332323
[TBL] [Abstract][Full Text] [Related]
13. A novel therapeutic strategy for hepatocellular carcinoma: Immunomodulatory mechanisms of selenium and/or selenoproteins on a shift towards anti-cancer.
Wu BK; Chen QH; Pan D; Chang B; Sang LX
Int Immunopharmacol; 2021 Jul; 96():107790. PubMed ID: 34162153
[TBL] [Abstract][Full Text] [Related]
14. Hepatic copper and other trace mineral concentrations in dogs with hepatocellular carcinoma.
Harro CC; Smedley RC; Buchweitz JP; Langlois DK
J Vet Intern Med; 2019 Sep; 33(5):2193-2199. PubMed ID: 31493348
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of nano-selenium in mitigating hepatocellular carcinoma induced by N-nitrosodiethylamine (NDEA) in rats.
Ahmed HH; Khalil WK; Hamza AH
Toxicol Mech Methods; 2014 Dec; 24(8):593-602. PubMed ID: 25156538
[TBL] [Abstract][Full Text] [Related]
16. Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma.
Ha YS; Lee GT; Kim YH; Kwon SY; Choi SH; Kim TH; Kwon TG; Yun SJ; Kim IY; Kim WJ
World J Surg Oncol; 2014 Sep; 12():288. PubMed ID: 25227434
[TBL] [Abstract][Full Text] [Related]
17. Selenium-binding protein 1 is down-regulated in malignant melanoma.
Schott M; de Jel MM; Engelmann JC; Renner P; Geissler EK; Bosserhoff AK; Kuphal S
Oncotarget; 2018 Feb; 9(12):10445-10456. PubMed ID: 29535818
[TBL] [Abstract][Full Text] [Related]
18. Selenium-Binding Protein 1 (SELENBP1) as Biomarker for Adverse Clinical Outcome After Traumatic Spinal Cord Injury.
Seelig J; Heller RA; Haubruck P; Sun Q; Georg Klingenberg J; Hackler J; Crowell HL; Daniel V; Moghaddam A; Schomburg L; Biglari B
Front Neurosci; 2021; 15():680240. PubMed ID: 34140879
[No Abstract] [Full Text] [Related]
19. Selenium binding protein 1 in ovarian cancer.
Huang KC; Park DC; Ng SK; Lee JY; Ni X; Ng WC; Bandera CA; Welch WR; Berkowitz RS; Mok SC; Ng SW
Int J Cancer; 2006 May; 118(10):2433-40. PubMed ID: 16380993
[TBL] [Abstract][Full Text] [Related]
20. Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer.
Wang Y; Zhu W; Chen X; Wei G; Jiang G; Zhang G
J Transl Med; 2020 Jan; 18(1):17. PubMed ID: 31918717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
